In vivo screening for anti-osteoporotic fraction from extract of herbal formula xianlinggubao in ovariectomized mice

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Wang, Xinluan ^a,b   He, Yixin ^b   Guo, Baosheng ^b   Tsang, Man Ching ^b   Tu, Fengjuan ^c   Dai, Yi ^c   Yao, Zhihong ^c   Zheng, Lizhen ^b   Xie, Xinhui ^b   Wang, Nan ^a   Yao, Xinsheng ^c   Zhang, Ge ^b   Qin, Ling ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; UNCLASSIFIED DRUG; XIANLINGGUBAO A; XIANLINGGUBAO B; XIANLINGGUBAO C; BONE DENSITY CONSERVATION AGENT; COUMARIN DERIVATIVE; TERPENE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOSTEOPOROTIC ACTIVITY; ARTICLE; BONE DEVELOPMENT; BONE METABOLISM; BONE STRENGTH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG SCREENING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MECHANICAL STIMULUS TEST; MICRO-COMPUTED TOMOGRAPHY; MINERALIZATION; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; OVARIECTOMY; PHYTOCHEMISTRY; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; FRACTIONATION; OSTEOPOROSIS; PRECLINICAL STUDY; RAT; TUMOR CELL LINE;

MUS;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; CELL LINE, TUMOR; CHEMICAL FRACTIONATION; COUMARINS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; FEMALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOPOROSIS; RATS; TERPENES;

EID: 84923250528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118184     Document Type: Article

References (56)

1. Lock CA, Lecouturier J, Mason JM, Dickinson HO (2006) Lifestyle interventions to prevent osteoporotic fractures: a systematic review. Osteoporos Int 17: 20-28. PMID: 15928799
2. QIN L, CHOY WY, HUANG WYV, Au SK, Chan KM, et al. (2014) Age-related vessel calcification at distal extremities is a risk factor of osteoporosis. Journal of Orthopaedic Translation 2: 43-48.
3. Notelovitz M (1997) Estrogen therapy and osteoporosis: principles & practice. Am J Med Sci 313: 2-12. PMID: 9001160
4. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333. PMID: 12117397
5. Mok SK, Chen WF, Lai WP, Leung PC, Wang XL, et al. (2010) Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol 159: 939-949. doi: 10.1111/j.1476-5381.2009.00593.x PMID: 20128811
6. Qin L, Zhang G, Hung WY, Shi Y, Leung K, et al. (2005) Phytoestrogen-rich herb formula "XLGB" prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats. J Bone Miner Metab 23 Suppl: 55-61. PMID: 15984415
7. Wang N, Wang XL, Cao HJ, Wang LY, Qin L (2014) Effect of psoralidin on inhibiting adipogenesis-an in vitro efficacy and mechanistic study. Journal of Orthopaedic Translation 2: 218.
8. Zhang G, Qin L, Shi YY (2007) Epimedium-Derived Phytoestrogen Flavonoids Exert Beneficial Effect on Preventing Bone Loss in Late Postmenopausal Women: A 24-Month Randomized, Double-Blind and Placebo-Controlled Trial. Journal of Bone and Mineral Research 22: 1072-1079 PMID: 17419678
9. Zhu HM, Qin L, Garnero P, Genant HK, Zhang G, et al. (2012) The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis. Osteoporos Int 23: 1317-1327. doi: 10.1007/s00198-011-1577-2 PMID: 21505910
10. Gui L, Shen H (2007) Application of Xianlinggubao in bone and arthrosis disease. Chin J New Drugs Clin Rem 26: 619-622.
11. Li XL, Liang GY, Cao PX, Guo BL (2010) HPLC simultaneous determination of epimedin B, epimedin C and icariin in Xianlinggubao capsules. Chin J Pharm Anal 30: 891-893.
12. Tao L, Shen XC, Yang RH, Bo S, Peng J (2009) Effect and mechanism of Jiangu Guben capsules on postmenopausal osteoporosis of variectomied rats. Chin Hosp Pharm J 29: 1431-1434.
13. Li Y, Lu SS, Tang GY, Hou M, Tang Q, et al. (2014) Effect of Morinda officinalis capsule on osteoporosis in ovariectomized rats. Chinese Journal of Natural Medicines 12: 204-212. doi: 10.1016/S1875-5364(14)60034-0 PMID: 24702807
14. Li QQ (2010) Xianlinggubao capsule in promoting fracture healing efficacy. China Modern Medicine 17: 96-97.
15. Hu CX, Cheng MF (2000) clinical observation on 30 casesof Xianlinggubao capsules in treatement of osteoporosis. Chinese Traditional Patent Medicine 22: 246-247.
16. Wu HC, Du SY, Lu Y, Chen W, Ma Y, et al. (2011) Comparative study of absorption kinetics in intestines of rats on Xianlinggubao capsule prepared by different technologies. China Journal of Chinese Materia Medica 36: 992-996. PMID: 21809569
17. Gao XZ, Ma LY, Jin YX, Zhang L, Tian JK (2010) Advances of studies on chemical constituents and pharmacological actions of Dipsacus Asperoides. Asia-Pacific Traditional Medicine 6: 142-146.
18. Liu CM, Liu ZQ, Dou JP, Li L, Liu SY (2003) Isolation and structure identification of the novel alkaloid constituent from Epimedium Koreanum Naki. Chemical Journal of Chinese University 24: 2215-2217.
19. Zhang RX, Li MX, Jia ZP (2008) Rehmannia glutinosa: review of botany, chemistry and pharmacology. J Ethnopharmacol 117: 199-214. doi: 10.1016/j.jep.2008.02.018 PMID: 18407446
20. Zhu Z, Zhang H, Zhao L, Dong X, Li X, et al. (2007) Rapid separation and identification of phenolic and diterpenoid constituents from Radix Salvia miltiorrhizae by high-performance liquid chromatography diode-array detection, electrospray ionization time-of-flight mass spectrometry and electrospray ionization quadrupole ion trap mass spectrometry. Rapid Commun Mass Spectrom 21: 1855-1865. PMID: 17510941
21. Hu CX, Cheng MF (2000) 30 clinical observation of Xianlinggubao capsule on treatment of osteoporosis. Chinese Traditional Patent Medicine 22: 246-247.
22. Mao YJ, Wu LG, Liu K, Xu JC, Si XL (2006) The report of Weilinxian capsules on improvement bone mineral density in 102 cases of patients with osteoporosis. Chinese Journal of Modern Applied Pharmaceutics 23: 416-418.
23. Wang XL, Wang NL, Zhang Y, Gao H, Pang WY, et al. (2008) Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (KUNZE) J. SM. on osteoblastic proliferation using an osteoblast-like cell line. Chem Pharm Bull (Tokyo) 56: 46-51. PMID: 18175973
24. Xiao HH, Dai Y,Wan HY,Wong MS, Yao XS (2011) Bone-protective effects of bioactive fractions and ingredients in Sambucus williamsii HANCE. Br J Nutr 106: 1802-1809. doi: 10.1017/S0007114511002546 PMID: 21736773
25. Huang JH, Huang xH, CHen ZY, Zheng QS, Sun RY (2004) Dose conversion among different animals and healthy volunteers in pharmacological study. Chin J Clin Pharmacol Ther 9: 1069-1072.
26. Zhang G, Guo BS, Wu H, Tang T, Zhang BT, et al. (2012) A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nature Medicine 18: 307-314. doi: 10.1038/nm. 2617 PMID: 22286306
27. Songlin P, Ge Z, Yixin H, Xinluan W, Pingchung L, et al. (2009) Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone. Bone 45: 534-544. doi: 10.1016/j.bone.2009.05.022 PMID: 19501202
28. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610. PMID: 3455637
29. Dong GC, Chen HM, Yao CH (2008) A novel bone substitute composite composed of tricalcium phosphate, gelatin and drynaria fortunei herbal extract. J Biomed Mater Res A 84: 167-177. PMID: 17607749
30. Malaval L, Gupta AK, Liu F, Delmas PD, Aubin JE (1998) LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: modulation by dexamethasone. J Bone Miner Res 13: 175-184. PMID: 9495510
31. Wang N, Wang X, Cheng W, Cao H, Zhang P, et al. (2013) Puerarin promotes osteogenesis and inhibits adipogenesis in vitro. Chin Med 8: 17. doi: 10.1186/1749-8546-8-17 PMID: 23965299
32. Guan XY, Li HF, Yang WZ, Lin CH, Sun C, et al. (2011) HPLC-DAD-MS(n) analysis and HPLC quantitation of chemical constituents in Xian-ling-gu-bao capsules. J Pharm Biomed Anal 55: 923-933. doi: 10.1016/j.jpba.2011.03.021 PMID: 21477963
33. Luo GA, Wang YM (1997) Primary discussion of Method and theory about effective components of Traditional Chinese Medicine. Traditional Chinese Medicine Patent Prescription 19: 44-45.
34. Reginster JY (2011) Antifracture efficacy of currently available therapies for postmenopausal osteoporosis. Drugs 71: 65-78. doi: 10.2165/11587570-000000000-00000 PMID: 21175240
35. Deng WM, Zhang P, Huang H, Shen YG, Yang QH, et al. (2012) Five-year follow-up study of a kidneytonifying herbal Fufang for prevention of postmenopausal osteoporosis and fragility fractures. J Bone Miner Metab 30: 517-524. doi: 10.1007/s00774-012-0351-7 PMID: 22722637
36. Mok SK, Chen WF, Lai WP, Leung PC, Wang XL, et al. (2010) Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol 159: 939-949. doi: 10.1111/j.1476-5381.2009.00593.x PMID: 20128811
37. Varea O, Arevalo MA, Garrido JJ, Garcia-Segura LM, Wandosell F, et al. (2010) Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system. Steroids 75: 565-569. doi: 10.1016/j.steroids.2009.09.006 PMID: 19778547
38. Zhang G, Qin L, Hung WY, Shi YY, Leung PC, et al. (2006) Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Bone 38: 818-825. PMID: 16413840
39. Liu M, Xiao GG, Rong P, Zhang Z, Dong J, et al. (2012) Therapeutic effects of Radix Dipsaci, Pyrola Herb, and Cynomorium Songaricum on bone metabolism of ovariectomized rats. BMC Complement Altern Med 12: 67. doi: 10.1186/1472-6882-12-67 PMID: 22639966
40. Wong RW, Rabie AB, Hagg EU (2007) The effect of crude extract from Radix Dipsaci on bone in mice. Phytother Res 21: 596-598. PMID: 17380551
41. Wong RW, Rabie AB (2010) Effect of Buguzhi (Psoralea corylifolia fruit) extract on bone formation. Phytother Res 24 Suppl 2: S155-160. doi: 10.1002/ptr.3049 PMID: 19953524
42. Lim SH, Ha TY, Kim SR, Ahn J, Park HJ, et al. (2009) Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats. Br J Nutr 101: 1031-1039. doi: 10.1017/S0007114508066750 PMID: 18801207
43. Chen WF, Mok SK, Wang XL, Lai KH, Lai WP, et al. (2011) Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. Br J Nutr 105: 180-189. doi: 10.1017/S0007114510003247 PMID: 20815976
44. Niu YB, Li YH, Kong XH, Zhang R, Sun Y, et al. (2012) The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. Osteoporos Int 23: 2649-2660. doi: 10.1007/s00198-012-1932-y PMID: 22535190
45. Liu ZG, Zhang R, Li C, Ma X, Liu L, et al. (2009) The osteoprotective effect of Radix Dipsaci extract in ovariectomized rats. J Ethnopharmacol 123: 74-81. doi: 10.1016/j.jep.2009.02.025 PMID: 19429343
46. Tsai MH, Huang GS, Hung YC, Bin L, Liao LT, et al. (2007) Psoralea corylifolia extract ameliorates experimental osteoporosis in ovariectomized rats. Am J Chin Med 35: 669-680. PMID: 17708633
47. Yang Z, Huang JH, Liu SF, Zhao YJ, Shen ZY, et al. (2012) The osteoprotective effect of psoralen in ovariectomy-induced osteoporotic rats via stimulating the osteoblastic differentiation from bone mesenchymal stem cells. Menopause 19: 1156-1164. PMID: 22781784
48. Cheng TO (2007) Cardiovascular effects of Danshen. Int J Cardiol 121: 9-22. PMID: 17363091
49. Liu YW, Zhu X, Lu Q, Wang JY, Li W, et al. (2012) Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats: involvement of amyloid-beta decrease in brain. J Ethnopharmacol 139: 194-200. doi: 10.1016/j.jep.2011.11.004 PMID: 22101084
50. Cremers S, Garnero P (2006) Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls. Drugs 66: 2031-2058. PMID: 17112299
51. Sorensen MG, Henriksen K, Schaller S, Karsdal MA (2007) Biochemical markers in preclinical models of osteoporosis. Biomarkers 12: 266-286. PMID: 17453741
52. Rissanen JP, Suominen MI, Peng Z, Morko J, Rasi S, et al. (2008) Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model. Calcif Tissue Int 82: 155-161. doi: 10.1007/s00223-007-9101-6 PMID: 18219436
53. Don MJ, Lin LC, Chiou WF (2012) Neobavaisoflavone stimulates osteogenesis via p38-mediated upregulation of transcription factors and osteoid genes expression in MC3T3-E1 cells. Phytomedicine 19: 551-561. doi: 10.1016/j.phymed.2012.01.006 PMID: 22397994
54. Park CK, Lee Y, Chang EJ, Lee MH, Yoon JH, et al. (2008) Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL. Biochem Pharmacol 75: 2175-2182. doi: 10.1016/j.bcp.2008.03.007 PMID: 18433733
55. Wang X, Zhen L, Zhang G, Wong MS, Qin L, et al. (2011) Osteogenic effects of flavonoid aglycones from an osteoprotective fraction of Drynaria fortunei-An in vitro efficacy study. Phytomedicine 18: 868-872. doi: 10.1016/j.phymed.2011.01.022 PMID: 21377852
56. Tan W, Yu KQ, Liu YY, Ouyang MZ, Yan MH, et al. (2012) Anti-fatigue activity of polysaccharides extract from Radix Rehmanniae Preparata. Int J Biol Macromol 50: 59-62. doi: 10.1016/j.ijbiomac.2011.09.019 PMID: 21983027